Английская Википедия:Achromobacter xylosoxidans

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Italic title Шаблон:Taxobox

Achromobacter xylosoxidans (formerly Alcaligenes xylosoxidans) is a Gram-negative, aerobic, oxidase and catalase-positive, motile bacterium with peritrichous flagella, from the genus Achromobacter. It is generally found in wet environments. Achromobacter xylosoxidans can cause infections such as bacteremia,[1][2] especially in patients with cystic fibrosis.[3] In 2013, the complete genome of an A. xylosoxidans strain from a patient with cystic fibrosis was sequenced.[4]

Bacteriology

A. xylosoxidans is a Gram-negative rod that does not form spores. It is motile, with peritrichous flagella that distinguish it from Pseudomonas species, and is oxidase-positive, catalase-positive, and citrate-positive. It is urease and indole-negative. It produces acid oxidatively from xylose, but not from lactose, maltose, mannitol, or sucrose. It grows well on MacConkey agar and other inhibitory growth media such as deoxycholate, Salmonella-Shigella, and nalidixic acid-cetrimide agars.[1][5][6]

It is usually resistant to a variety of antibiotics including penicillins, cephalosporins, quinolones, and aminoglycosides. Ampicillin and carbenicillin, which are penicillins, are an exception. It is variably susceptible to tetracyclines, chloramphenicol, trimethoprim-sulfamethoxazole, and colistin.[5]

Pathogenesis and clinical characteristics

Originally isolated from patients with otitis media,[5] A. xylosoxidans has since been periodically described as a pathogen of humans. In addition to otitis, it can cause a variety of other infections, including pneumonia, pharyngitis, peritonitis in association with catheters used for peritoneal dialysis, and urinary tract infections.[1][7] Infection is sometimes associated with underlying immunodeficiency, including immunoglobulin M deficiency, various cancer chemotherapies, inhaled steroids, surgical procedures, prolonged or broad-spectrum antimicrobial treatment for other infections,[1] and cystic fibrosis.[3] It has also been the cause of hospital-acquired infections.[7]

See also

References

Шаблон:Reflist

External links

Шаблон:Taxonbar


Шаблон:Betaproteobacteria-stub